Literature DB >> 7451410

Comparative studies on alveolar macrophages and polymorphonuclear leukocytes. II. The ability of guinea pig alveolar macrophages to produce H2O2.

M Kaneda, K Kakinuma, T Yamaguchi, K Shimada.   

Abstract

Guinea pig alveolar macrophages (A-M0) were studied with respect ot the phagocytic metabolism: the respiratory burst and its KCN sensitivity, the ability to generate H2O2, and myeloperoxidase (MPO) activity. Only fifty percent of the O2 uptake by A-M0 samples during phagocytosis was inhibited by the addition of 1 mK KCN. Guinea pig A-M0 released H2O2 amounting to 7.7 and 12.5 nmol/min/10(7) cells upon addition of E. coli in the absence and presence of anti-E. coli antibody, respectively. Myristic acid, an effective membrane activator, induced a marked release of H2O2 amounting to 16.1 nmol/min/10(7) cells. We observed a high MPO activity in some alveolar lavage cells which contained a large number of polymorphonuclear leukocytes (PMN), but none at all in preparations containing fewer PMN. The MPO activity detected did not seem to be due to A-M0, but to the PMN contained in the preparations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7451410     DOI: 10.1093/oxfordjournals.jbchem.a133070

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Acute and progressive lung injury after contact with phorbol myristate acetate.

Authors:  K J Johnson; P A Ward
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

2.  Hydrogen peroxide and superoxide release by alveolar macrophages from normal and BCG-vaccinated guinea-pigs after intravenous challenge with Mycobacterium tuberculosis.

Authors:  P S Jackett; P W Andrew; V R Aber; D B Lowrie
Journal:  Br J Exp Pathol       Date:  1981-08

3.  Serum factor requirement for reactive oxygen intermediate release by rabbit alveolar macrophages.

Authors:  G F Gerberick; J B Willoughby; W F Willoughby
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.